Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the …
X Wang, D Goldstein, PJ Crowe… - OncoTargets and …, 2016 - Taylor & Francis
Tyrosine kinase inhibitors (TKIs) against human epidermal growth factor receptor
(EGFR/HER) family have been introduced into the clinic to treat cancers, particularly non …
(EGFR/HER) family have been introduced into the clinic to treat cancers, particularly non …
Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients
LY Wang, JJ Cui, AX Guo, JY Yin - OncoTargets and therapy, 2018 - Taylor & Francis
Compared with various malignant tumors, lung cancer has high incidence and the highest
mortality worldwide. Non-small-cell lung cancer (NSCLC), the most common kind of lung …
mortality worldwide. Non-small-cell lung cancer (NSCLC), the most common kind of lung …
[HTML][HTML] Afatinib in patients with advanced non-small cell lung cancer harboring HER2 mutations, previously treated with chemotherapy: A phase II trial
Y Fan, J Chen, C Zhou, H Wang, Y Shu, J Zhang… - Lung Cancer, 2020 - Elsevier
Abstract Background Despite 1–4% of NSCLC tumors harboring mutations in the HER2
gene, there are no approved HER2-pathway-targeted treatments available. We report an …
gene, there are no approved HER2-pathway-targeted treatments available. We report an …
Solid phase extraction-based magnetic carbon nitride/metal organic framework composite with high performance liquid chromatography for the determination of …
D Liu, J Peng, L Chen, Y Zhang, X Han, P Yang… - Analytical …, 2020 - pubs.rsc.org
In this study, a novel solid phase extraction method was constructed to detect three tyrosine
kinase inhibitors (TKIs) in urine with a high-performance liquid chromatography-diode array …
kinase inhibitors (TKIs) in urine with a high-performance liquid chromatography-diode array …
[Retracted] Study on the Evaluation of Lung Cancer Patients from the Three Aspects of Emotion
P Li, J Yu, X Wang, X Pang, C Yu… - Contrast Media & …, 2022 - Wiley Online Library
In recent years, epidemiological survey data have shown that lung cancer is the tumor with
the fastest increase in cancer incidence and mortality in China. The incidence and mortality …
the fastest increase in cancer incidence and mortality in China. The incidence and mortality …
Survival outcomes in EGFR mutation-positive lung cancer patients treated with gefitinib until or beyond progression
FV Moiseyenko, VM Moiseyenko… - Oncology Research …, 2016 - karger.com
Background: Discontinuation of gefitinib treatment is often accompanied by a disease flare.
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Роль ингибиторов EGFR 2-го поколения в терапии рака легкого в реалиях современной клинической практики
АА Измайлов, АФ Насретдинов… - Онкология. Журнал им …, 2021 - elibrary.ru
Современные ингибиторы тирозинкиназ (ИТК) 3-го поколения показывают
поразительные результаты в лечении EGFR-мутированных опухолей легкого …
поразительные результаты в лечении EGFR-мутированных опухолей легкого …